Skip to main content
Premium Trial:

Request an Annual Quote

454, WashU Pen Sequencing, Gene-Expression Alliance

NEW YORK, Dec. 7 (GenomeWeb News) - 454 Life Sciences and the Genome Sequencing Center at the Washington University School of Medicine plan to sequence disease-causing pathogens and study expression profiles of genes in mammalian cells and tissues, the partners said today.


The first part of the plan calls for GSC and 454 scientists to sequence and analyze the genomes of disease-causing pathogens using 454's Genome Sequencer 20 System. During the second part of the plan, scientists from the two partners will sequence RNA to assess the expression profiles of genes in mammalian cells and tissues.


Christopher McLeod, 454's president and CEO, noted that the cooperation "could be expanded to incorporate additional research topics in the future."


Financial details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.